CNBC Pro

Morgan Stanley names Eli Lilly a top pick, says it has best product outlook in pharma

The Eli Lilly logo is shown on one of the company's offices in San Diego, California, September 17, 2020.
Mike Blake | Reuters

A slate of upcoming product launches including an exciting drug for diabetes and weight loss makes Eli Lilly a top pick among pharmaceuticals, according to Morgan Stanley.

More In Street Calls

CNBC ProGoldman Sachs analysts reveal some of the most 'attractive' stocks as recession fears mount
CNBC ProHere are Friday's biggest analyst calls: Tesla, Apple, Sunoco, Exxon, Microsoft, Uber & more
CNBC ProRecords storage stock Iron Mountain offers resilience in a volatile world, Barclays says